Therapeutic Areas: Psychiatry

Choose Therapeutic Area
Oncology
Cardiology
Ophthalmology
Neurology
Endocrinology
Gastroenterology
Dermatology
Urology
Infectious diseases incl. Covid-19
Psychiatry
Rare diseases
Cromos Pharma has a team of experts with extensive experience in conducting clinical trials in psychiatric disorders, including depression, anxiety, bipolar disorder, schizophrenia, and other mental illnesses

Our team has a deep understanding of the complex issues involved in conducting psychiatric clinical trials, such as patient recruitment and retention, placebo response, and regulatory requirements.

In addition to traditional clinical trial services, Cromos Pharma has specialized expertise in neuroimaging, genetics, and biomarker analysis. We provide access to specialized patient populations, including those with treatment-resistant depression or comorbid medical conditions.

One of our key offerings is the ability to provide customized study-specific solutions. Cromos Pharma works closely with its clients to understand their exact needs and tailor its services accordingly. We have a successful track record of developing innovative recruitment strategies to overcome the challenges of recruiting patients with specific psychiatric disorders.

Another important offering that Cromos Pharma provides is its expertise in regulatory compliance. We have a deep understanding of the regulatory requirements for psychiatric clinical trials and can help our clients navigate the complex regulatory landscape. We can also provide guidance on the development of study protocols, informed consent forms, and other essential documents.

By leveraging its knowledge and experience, Cromos Pharma can help overcome the unique challenges of conducting clinical research in this complex and rapidly evolving field.

Our psychiatric experience includes:
    • Anxiety
    • Bipolar disorder
    • Major Depression
    • Moderate Cognitive Impairment

     

    • OCD
    • Panic Disorder
    • PTSD
    • Schizophrenia
Cromos Pharma Psychiatry experience in the last five years
5,000
Patients
20
Studies
400
Clinical Sites
our Success story
A Phase III Schizophrenia trial
Click to openclose
Why Cromos Pharma
  • We are the only CRO to offer “No Patients, No Payment” risk sharing program, where the sponsor pays only if we deliver on our milestones.
  • We have the scientific and clinical expertise to support your clinical studies, from early to late phase, from single- to multi-country execution strategies.
  • By leveraging our international expertise, we deliver unparalleled results through diligent feasibility analysis, rapid startup, and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
  • Our team has vast expertise in organizing scientific advisory board meetings of key opinion leaders, clinicians, and industry stakeholders.

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM

more therapeutics